Formulating an evidence-based treatment algorithm for neuropathic pain should be based on a number of factors, including a consistent outcome in randomized controlled studies of high quality ...

Although systematic reviews have outlined the current treatment options for neuropathic pain, subsequent trials have necessitated an update of the NUMBER NEEDED TO TREAT (NNT) values presented in ...

A new study by Monash University medicine safety experts found the use of gabapentinoids—medicines widely used to treat ...

Cannabidiol (CBD) holds great promise as a treatment ... pain, there’s a chance it may work for nerve pain. Neuropathy, or nerve dysfunction, doesn’t always result in nerve pain, or ...

Neuropathic pain affects more than 20 million people in the U.S., and at least a quarter of these cases are puzzling for ...

Often seen as a safer alternative to opioids for the treatment of neuropathic pain, gabapentinoid use increased eightfold between 2012 and 2018, with one in seven Australians aged 80 and older ...

ITDD helps effectively manage chronic pain and spasticity in some patients but requires adherence to best practices and a ...

Neuropathic pain ... in transmitting sensitivity to pain. People with a genetic variant in opioid receptors may need higher doses of painkillers for the treatment of pain. Interestingly, one ...

Researchers have found pregabalin highly effective in reducing neuropathic pain and itch in recessive dystrophic epidermolysis bullosa (RDEB), the most prevalent and debilitating form ...

Ketamir-2, a non-opioid, offers tremendous promise for patients seeking better solutions for neuropathic pain without the habit ... aimed at mental health treatment. These grants could help ...

A new study by Monash University medicine safety experts found the use of gabapentinoids – medicines widely used to treat neuropathic pain – increased the risk of hip fractures, especially in older ...